AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Pier Luigi Zinzani

Pier Luigi Zinzani

Università di Bologna - Bologna / Italy
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1854095
University of Bologna
person_outline Pier Luigi Zinzani's MOST POPULAR ARTICLES
1-) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by … The lancet oncology 7 (5), 379-391, 2006
2-) Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial The Lancet 376 (9747), 1164-1174, 2010
3-) Follicular lymphoma international prognostic index Blood 104 (5), 1258-1265, 2004
4-) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022
5-) PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma New England Journal of Medicine 370 (11), 1008-1018, 2014